This chart shows the share of respondents in a selection of countries who said they suffer from cardiovascular diseases.

CVD risk in the moderate-to-low declining cardiovascular health (CVH) group was 9.96 times that of the persistently high CVH ...

Pre-existing maternal CVD rates rose from 2.31% in 2001 to 5.83% in 2019, with CVD more common in older age groups.

Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health ...

Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat ...

An expert discusses the growing burden of atherosclerotic cardiovascular disease (ASCVD) in the U.S., emphasizing the ...

An expert discusses how chronic kidney disease (CKD), often underdiagnosed and poorly recognized, is intricately linked with cardiovascular and metabolic conditions, emphasizing the urgent need for ...

Coronary artery calcium (CAC) is a marker of subclinical atherosclerosis that confers increased risk of atherosclerotic cardiovascular disease. Measured by noncontrast cardiac computed tomography, CAC ...

Heart disease is the No. 1 cause of death in the United States. These are the steps you need to take to reduce your risk.

A new study suggests a combination of cardiovascular drugs, pemafibrate and telmisartan, may reverse fatty liver disease by ...

For more than 20 years nationally, the American Heart Association's signature women's initiative, Go Red for Women, has met ...

BACKGROUND: Cardiac and vascular complications are the leading causes of maternal mortality and morbidity, but the ...